XRAY Stock Forecast: Dentsply Sirona, Inc. Price Predictions for 2026-2027
The 17 Wall Street analysts covering Dentsply Sirona, Inc. hold a median 12-month price target of $11 — +32.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 78 of 100 as at 21 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.
One number for the whole business
Consensus tells you what everyone already believes. The model scores Dentsply Sirona, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (97): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Revisions (29): Analysts have, on balance, been cutting their forecasts.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
XRAY stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on XRAY, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +32.8% from it.
Of the 20 most recent actions, 2 moved their price target up and 7 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 16 Nov 2026 | UBS | Maintains | Buy | $17 → $13 |
| 7 Nov 2026 | JP Morgan | Maintains | Neutral | — |
| 6 Nov 2026 | JP Morgan | Maintains | Neutral | $12 → $10 |
| 26 Oct 2026 | Barrington Research | Maintains | Outperform | $15 → $13 |
| 22 Oct 2026 | Mizuho | Maintains | Neutral | $14 → $12 |
| 14 Oct 2026 | Leerink Partners | Maintains | Market Perform | $14 → $10 |
| 9 Oct 2026 | Piper Sandler | Maintains | Neutral | $14 → $12 |
| 17 Sept 2026 | BMO Capital | Maintains | Market Perform | $13 → $10 |
| 24 Aug 2026 | Barclays | Maintains | Underweight | $9.00 → $11 |
| 29 July 2026 | Piper Sandler | Maintains | Neutral | $13 → $14 |
| 9 July 2026 | BMO Capital | Initiates | Market Perform | — |
| 4 June 2026 | Barclays | Maintains | Underweight | — |
| 7 May 2026 | UBS | Maintains | Buy | — |
| 6 May 2026 | Mizuho | Maintains | Neutral | — |
| 15 Apr 2026 | Citigroup | Initiates | Sell | — |
| 2 Mar 2026 | Barrington Research | Maintains | Outperform | — |
| 2 Mar 2026 | Mizuho | Maintains | Neutral | — |
| 27 Feb 2026 | Baird | Maintains | Neutral | — |
| 27 Feb 2026 | Evercore ISI Group | Maintains | In-Line | — |
| 27 Feb 2026 | Wells Fargo | Maintains | Equal-Weight | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for XRAY.
This page is one stock. Monday covers all of them.
XRAY appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
XRAY vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, Dentsply Sirona, Inc. returned −15.1% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
XRAY analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 0.5×
- Price / book
- 1.2×
- EV / EBITDA
- 7.4×
Cheaper than 80% of US stocks
Cheaper than 64% of US stocks
Cheaper than 71% of US stocks
- Revenue growth (YoY)
- −7.5%
- Earnings growth (YoY)
- —
- Gross margin
- 54.9%
- Operating margin
- 4.7%
- Net margin
- —
Higher than 18% of US stocks
Higher than 68% of US stocks
Higher than 52% of US stocks
- Return on equity
- −8.6%
- Return on assets
- 1.9%
- Dividend yield
- 7.7%
Higher than 37% of US stocks
Higher than 57% of US stocks
Higher than 87% of US dividend payers
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
Dentsply Sirona, Inc. has a market value of $1.7B and an enterprise value of $3.8B.
Revenue in the twelve months to 30 June 2026: $3.6B. The latest quarter shrank 4.1% year on year.
Net income over the same four quarters: −$547.0M, a −15.0% net margin.
Diluted earnings per share, trailing twelve months: −$2.75.
Free cash flow in the twelve months to 30 June 2026: $143.0M, after $176.0M of capital spending.
Dentsply Sirona, Inc. spent $96.0M on dividends in the twelve months to 30 June 2026.
forward P/E: 6.8× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 7.72%.
Dentsply Sirona, Inc. employs 14,000 people — $260K of revenue per employee.
Data provided by Twelve Data
XRAY and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at XRAY’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own Dentsply Sirona, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about XRAY
What is the XRAY stock price forecast for 2026-2027?
The 17 Wall Street analysts covering Dentsply Sirona, Inc. have a median 12-month price target of $11, with estimates ranging from $8 to $14. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is XRAY stock a buy right now?
Of the 17 analysts covering Dentsply Sirona, Inc., 4 rate it a Buy, 12 a Hold and 1 a Sell. Ticker Nerd's systematic factor model ranks Dentsply Sirona, Inc. 78 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank XRAY?
As at 21 Nov 2026, Dentsply Sirona, Inc. ranks 78 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Value (97 of 100).
Will XRAY stock go up?
No one can know that. What the data says: the median 12-month target from 17 analysts implies +32.8% from the last close, and Ticker Nerd's factor model ranks Dentsply Sirona, Inc. 78 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the XRAY stock forecast for 2030?
No analyst covering Dentsply Sirona, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for XRAY are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $8 to $14 over the next 12 months.
How has XRAY stock performed over the past year?
Dentsply Sirona, Inc. returned -15.1% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does Dentsply Sirona, Inc. do?
Dentsply Sirona Inc. is a global dental products and technologies company that serves dental practices, clinics, laboratories, and distributors worldwide. The company develops, manufactures, and markets a broad portfolio that includes dental consumables, restorative materials, digital imaging systems, CAD/CAM restoration platforms, treatment centers, handpieces, hygiene systems, orthodontic and implant products, and specialty solutions for endodontics and other oral care applications.
About Dentsply Sirona, Inc.
Dentsply Sirona Inc. is a global dental products and technologies company that serves dental practices, clinics, laboratories, and distributors worldwide. The company develops, manufactures, and markets a broad portfolio that includes dental consumables, restorative materials, digital imaging systems, CAD/CAM restoration platforms, treatment centers, handpieces, hygiene systems, orthodontic and implant products, and specialty solutions for endodontics and other oral care applications. Dentsply Sirona also provides workflow-oriented technologies designed to support diagnosis, treatment planning, and chairside procedures across modern dental settings. Headquartered in Charlotte, North Carolina, Dentsply Sirona is a major supplier in the professional dental market, combining equipment, software-enabled tools, and everyday consumables to support clinical efficiency and patient care.
CEO Mr. Daniel T. Scavilla · 14,000 employees · United States · https://www.dentsplysirona.com